Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 243

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Synaptic functions of endocannabinoid signaling in health and disease

Open access
Araque, Alfonso, Castillo, Pablo E., Manzoni, Olivier J., Tonini, Raffaella·2017·Neuropharmacology

Abstract

Abstract Endocannabinoids (eCBs) are a family of lipid molecules that act as key regulators of synaptic transmission and plasticity. They are synthetized “on demand” following physiological and/or pathological stimuli. Once released from postsynaptic neurons, eCBs typically act as retrograde messengers to activate presynaptic type 1 cannabinoid receptors (CB1) and induce short‐ or long‐term depression of neurotransmitter release. Besides this canonical mechanism of action, recent findings have revealed a number of less conventional mechanisms by which eCBs regulate neural activity and synaptic function, suggesting that eCB‐mediated plasticity is mechanistically more diverse than anticipated. These mechanisms include non‐retrograde signaling, signaling via astrocytes, participation in long‐term potentiation, and the involvement of mitochondrial CB1. Focusing on paradigmatic brain areas, such as hippocampus, striatum, and neocortex, we review typical and novel signaling mechanisms, and discuss the functional implications in normal brain function and brain diseases. In summary, eCB signaling may lead to different forms of synaptic plasticity through activation of a plethora of mechanisms, which provide further complexity to the functional consequences of eCB signaling. This article is part of the Special Issue entitled “A New Dawn in Cannabinoid Neurobiology”. HighlightsEndocannabinoids (eCBs) regulate both synaptic function and neuronal excitability.eCB signaling is complex and may involve astrocytes and non‐retrograde signaling.eCBs can mediate short and long‐term changes of synaptic transmission.Disrupted eCB signaling may contribute to brain disorders (e.g. autism, dementia).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2017.06.017

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 243

Metadata

Authors
Araque, A., Castillo, P. E., Manzoni, O. J., & Tonini, R.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2017-09
Volume
124
Pages
13-24
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2625908954
Cited by
243
References
34
FWCI
15.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synaptic functions of endocannabinoid signaling in health and disease. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.06.017
The paper
Araque, A., Castillo, P. E., Manzoni, O. J., & Tonini, R. (2017). Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.06.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.